A
Alexandra Giatromanolaki
Researcher at Democritus University of Thrace
Publications - 360
Citations - 26647
Alexandra Giatromanolaki is an academic researcher from Democritus University of Thrace. The author has contributed to research in topics: Angiogenesis & Cancer. The author has an hindex of 66, co-authored 340 publications receiving 22956 citations. Previous affiliations of Alexandra Giatromanolaki include John Radcliffe Hospital.
Papers
More filters
Journal Article
Endometrial carcinoma and diabetes revisited.
Nikolaos Papanas,Alexandra Giatromanolaki,George Galazios,Efstratios Maltezos,Efthimios Sivridis +4 more
TL;DR: Results indicate that endometrial adenocarcinoma is not intrinsically different in diabetic patients, but long-term survival and other clinical and histological features were the same in the two groups.
Journal ArticleDOI
Differential assessment of angiogenic activity and of vascular survival ability (VSA) in breast cancer.
Alexandra Giatromanolaki,Efthimios Sivridis,Constantinos Simopoulos,Alexandros Polychronidis,Kevin C. Gatter,Adrian L. Harris,Michael I. Koukourakis +6 more
TL;DR: Recognition and quantification of the vascular survival ability in human tumors may significantly improve the prognostic value of the assessment of tumor vasculature, and may help to stratify patients for clinical trials with novel anti-angiogenic or angiotoxic drugs.
Journal ArticleDOI
Inferior nasal turbinate wound healing after submucosal radiofrequency tissue ablation and monopolar electrocautery: histologic study in a sheep model.
Haralampos Gouveris,Christina Nousia,Alexandra Giatromanolaki,Maria Riga,Michael Katotomichelakis,Petros Ypsilantis,Efthimios Sivridis,Vassilios Danielides +7 more
TL;DR: To study differences in inferior nasal turbinate mucosal and submucosal wound‐healing histology after radiofrequency tissue ablation (RTA) and monopolar electrocautery (MEC), data are collected on mice treated with RTA and MEC.
Journal ArticleDOI
Interferon regulatory factor-1 (IRF-1) suppression and derepression during endometrial tumorigenesis and cancer progression.
Alexandra Giatromanolaki,Michael I. Koukourakis,Konstantinos Ritis,Konstantinos Mimidis,Efthimios Sivridis +4 more
TL;DR: It is concluded that down-regulation of IRF-1 is a constant finding in endometrial tumorigenesis, however, derepression of IRf-1 may occur in a subset of tumors, and this event is associated with TP up-regulation and aggressive tumor behavior.
Journal ArticleDOI
Inhibition of IKK-NFκB pathway sensitizes lung cancer cell lines to radiation.
Avgi Tsolou,Maria Liousia,Dimitra Kalamida,Stamatia Pouliliou,Alexandra Giatromanolaki,Michael I. Koukourakis +5 more
TL;DR: The genetic or pharmacological blockage of the RAF1-ERK-IKK-NFκB pathway sensitizes cells to therapeutic doses of radiation, and the IKK pathway is a promising target for therapeutic intervention in combination with radiotherapy.